Diagnologix LLC is startup company that focuses on developing innovative diagnostic tools and products for unmet medical needs. The firm is developing upstream technologies to isolate rare circulating tumor cells for in vitro culture using matrix microarray technology developed by MicroStem, Inc.; in collaboration with investigators at UCSD, the technology is being prepared for clinical applications. In addition, Diagnologix had developed, in partnership with College of Charleston, the Innovative 3D imaging technologies for the screening and therapeutic monitoring of tumor growths.
